Onconova Therapeutics, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 5.99%66.360.0%$1015.60m
NVAXNovavax, Inc. 7.89%101.80251.8%$824.79m
AMGNAmgen, Inc. 1.07%251.711.3%$701.22m
REGNRegeneron Pharmaceuticals, Inc. 0.61%624.622.5%$667.04m
GILDGilead Sciences, Inc. 1.07%77.141.0%$637.58m
BIIBBiogen, Inc. 0.47%280.201.6%$604.41m
VRTXVertex Pharmaceuticals, Inc. 0.08%294.681.9%$475.89m
VXRTVaxart, Inc. 24.00%9.900.0%$355.93m
ILMNIllumina, Inc. 1.45%375.603.5%$305.54m
ALXNAlexion Pharmaceuticals, Inc. -0.13%108.682.0%$216.91m
BMRNBioMarin Pharmaceutical, Inc. 1.33%127.734.3%$209.55m
SGENSeattle Genetics, Inc. 0.13%174.586.1%$192.64m
SRNESorrento Therapeutics, Inc. -2.73%7.841.8%$187.59m
IMMUImmunomedics, Inc. 1.28%41.8511.0%$179.27m
BNTXBioNTech SE 13.55%79.890.0%$177.75m

Company Profile

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.